<DOC>
	<DOCNO>NCT00316147</DOCNO>
	<brief_summary>In study , infants previously vaccinate hepatitis B vaccine birth randomly allocate two group : - one group subject receive diphtheria , tetanus , acellular pertussis- hepatitis B virus-inactivated poliovirus/Haemophilus influenzae type b ( DTPa-HBV-IPV/Hib ) vaccine 6-10-14 week age - second group subject receive DTPa-HBV-IPV/Hib vaccine 2-4-6 month age</brief_summary>
	<brief_title>Immunogenicity &amp; Safety GSK 's Combined DTPa-HBV-IPV/Hib Vaccine Indian Infants 2 Diff Vaccination Schedules</brief_title>
	<detailed_description>DTPa-HBV-IPV/Hib vaccine administer two schedule ( i.e . 6-10-14 week age OR 2-4-6 month age ) infants previously vaccinate hepatitis B vaccine birth . The duration study approximately 3 month subject receive vaccination 6-10-14 week age approximately 5 month subject receive vaccination 2-4-6 month age . Intervention name : Diphteria , tetanus , acellular pertussis , hepatitis B , poliovirus type 1 , 2 , 3 &amp; Haemophilus influenzae type b vaccine</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A healthy male female infant , include , 6 10 week age time first vaccination . Written inform consent obtain parent guardian subject . Born normal gestation period ( 36 42 week ) . Should receive birth dose hepatitis B vaccine , evidence vaccination/immunisation certificate . Use investigational nonregistered product ( vaccine drug ) study vaccine within 30 day precede first dose study vaccine , plan use study period . Chronic administration ( defined 14 day ) immunosuppressant immunemodifying drug prior first vaccine dose . Any chronic drug therapy continue study period . Planned administration/administration vaccine foreseen study protocol period start 30 day administration first vaccine dose end 30 day last dose ( exception oral polio vaccine birth dose pulse polio program , per local , regional , national requirement ) . Previous vaccination diphtheria , tetanus , pertussis , poliomyelitis Haemophilus influenzae type b disease . Known exposure diphtheria , tetanus , Bordetella pertussis , hepatitis B , poliomyelitis Haemophilus influenzae type b disease since birth .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>10 Weeks</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>diphtheria</keyword>
	<keyword>tetanus</keyword>
	<keyword>poliomyelitis</keyword>
	<keyword>pertussis</keyword>
	<keyword>hepatitis B</keyword>
	<keyword>Prophylaxis</keyword>
	<keyword>Haemophilus influenza type b disease</keyword>
</DOC>